eccDNA always reversibly drives the up-regulation or inhibition of mutant EGFR, thereby leading to a growth advantage in tumors with cells resistant to EGFR-targeted tyrosine kinase inhibitors after treatment, in glioblastoma cells.21 Here, EGFR is linked to glioblastoma.